肠菌移植:从经验治疗迈向精准规范化时代
作者:
通讯作者:
作者单位:

消化疾病国家临床研究(上海)分中心/苏州市立医院/南京医科大学附属苏州医院;苏州市重大慢病与肠道微生态重点 实验室,江苏 苏州 215008

作者简介:

秦环龙,苏州市立医院/南京医科大学附属苏州医院主任医师,主要从事肠道微生态及胃肠肿瘤方面的研究。

基金项目:

国家自然科学基金资助项目(82300753);江苏省前沿技术(卫生健康领域)计划基金资助项目(BF2025637);国家重点研发计划基金资助项目(2024YFA1307101);南京医科大学姑苏学院肠道菌群专项基金资助项目(GSKY20250802,GSKY20250807);南京医科大学姑苏学院博士科研启动基金资助项目(Szslyyrc202601036)。


Fecal microbiota transplantation: from empirical therapy to the era of precision and standardized medicine
Author:
Affiliation:

Branch Center of National Clinical Research Center for Digestive Diseases (Shanghai)/Suzhou Municipal Hospital/the Affiliated Suzhou Hospital of Nanjing Medical University;Suzhou Key Laboratory for Major Chronic Diseases and Intestinal Microecology, Suzhou, Jiangsu 215008, China

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 音频文件
  • |
  • 视频文件
    摘要:

    肠菌移植(FMT)作为重塑肠道微生态的重要生物治疗策略,已从早期经验性用于复发性艰难梭菌感染,逐步拓展至炎症性肠病、功能性胃肠疾病、慢性肝病以及神经精神疾病等多种肠内外疾病,并正在向精准化、规范化和机制导向的微生态治疗阶段发展。本文结合近十年来国内外FMT领域的重要研究进展及本团队的大规模临床实践经验,围绕“经验治疗—标准化实践—精准干预”的发展主线,系统综述FMT在供体筛选与质量控制、肠道微生物组检测、供受体精准配型、治疗时机与疗程优化、移植途径选择、疗效评估体系构建及长期随访管理等方面的关键问题与挑战,同时总结FMT在“菌-肠-器官轴”调控、活菌生物药、噬菌体疗法等新兴方向的研究进展。未来FMT的发展将更加依赖多组学技术、人工智能配型及功能菌群解析,推动FMT从经验性操作向精准、可控和可复制的微生态治疗模式转变。

    Abstract:

    Fecal microbiota transplantation (FMT), as an important biological strategy for reconstructing intestinal microecology, has evolved from an empirical therapy for recurrent Clostridioides difficile infection to a promising intervention for a wide range of intestinal and extraintestinal diseases, including inflammatory bowel disease, functional gastrointestinal disorders, chronic liver diseases, and neuropsychiatric disorders. FMT is currently transitioning toward an era of precision, standardization, and mechanism-oriented microecological therapy. Based on major advances in FMT research over the past decade and the extensive clinical experience of our team, this review systematically summarizes the developmental trajectory of FMT from "empirical treatment-standardized practice-precision intervention". Key issues and challenges are discussed, including donor screening and quality control, gut microbiome detection, donor-recipient matching, optimization of treatment timing and therapeutic courses, selection of transplantation routes, establishment of efficacy evaluation systems, and long-term follow-up management. In addition, recent progress in emerging fields such as the gut-organ axis, live biotherapeutic products, and bacteriophage therapy is highlighted. Future development of FMT will increasingly rely on multi-omics technologies, artificial intelligence-assisted matching strategies, and functional microbiota analysis, thereby promoting the transformation of FMT from an empirical intervention into a precise, controllable, and reproducible microecological therapeutic modality.

    图1 FMT通过“菌-肠-器官轴”调控远隔器官的机制示意图Fig.1 Schematic diagram illustrating the mechanisms by which FMT regulates distant organs via the gut-organ axis
    参考文献
    相似文献
    引证文献
引用本文

范俊杰,王新军,黄龙,秦环龙.肠菌移植:从经验治疗迈向精准规范化时代[J].中国普通外科杂志,2026,35(4):684-695.
DOI:10.7659/j. issn.1005-6947.260028

复制
文章指标
  • 点击次数:
  • 下载次数:
历史
  • 收稿日期:2026-01-15
  • 最后修改日期:2026-03-23
  • 录用日期:
  • 在线发布日期: 2026-06-04
通知

编辑部电话线路临时维护,暂无法接通。查稿咨询请发送邮件至:pw84327400@vip.126.com,我们将第一时间回复。

关闭